Idexx Laboratories IDXX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| CAG | $1.05B+14.6% | $998.47M+14.7% | $1.01B+13.5% | $1.02B+10.9% | $919.84M+3.4% | |
| LPD | $32.48M+13.6% | $37.49M+8.5% | $33.94M+17.1% | $31.76M+4.8% | $28.6M+1.4% | |
| Water segment revenue | $50.27M+10.9% | $50.53M+11.9% | $54.3M+8.2% | $51M+9.1% | $45.32M+5.2% | |
| Gross Profit by Business | ||||||
| CAG | $667.51M+16.1% | $604.29M+16.3% | $627.46M+15.2% | $642.1M+12.8% | $574.82M+5.2% | |
| LPD | $16.91M+17.7% | $18.97M+10.7% | $15.95M+9.0% | $14.93M-4.0% | $14.37M-5.7% | |
| Water segment revenue | $36.54M+13.9% | $33.65M+2.9% | $38.06M+9.5% | $35.51M+10.7% | $32.07M+5.2% | |
| Cost of revenue by Business | ||||||
| CAG | $386.54M+12.0% | $394.18M+12.3% | $385.08M+10.8% | $380.34M+7.7% | $345.01M+0.6% | |
| LPD | $15.57M+9.4% | $18.52M+6.3% | $18M+25.3% | $16.83M+14.1% | $14.23M+9.7% | |
| Water segment revenue | $13.73M+3.6% | $16.88M+35.4% | $16.24M+5.4% | $15.49M+5.7% | $13.25M+5.4% | |
| Total Revenue by Product | ||||||
| CAG Diagnostics capital - instruments | $42.45M+32.7% | $58.13M+76.1% | $51.48M+74.3% | $58.6M+66.0% | $31.99M-6.2% | |
| Rapid assay products | $84.94M+1.1% | $76.04M-1.7% | $88.64M-4.5% | $100.24M-3.0% | $84.03M-2.6% | |
| Recurring revenue | $73.54M+11.8% | $70.6M+12.2% | $70.99M+9.8% | $68.95M+9.2% | $65.79M+10.2% | |
| Reference laboratory diagnostic and consulting services | $386.18M+12.1% | $349.25M+10.5% | $362.73M+10.5% | $367.69M+5.8% | $344.41M0.0% | |
| Systems and hardware | $17.75M+12.5% | $20.07M+17.3% | $16.79M+16.8% | $16.89M+9.5% | $15.78M+2.8% | |
| Cost of revenue by Product | ||||||
| Product revenue | $194.43M+10.8% | $216.98M+19.0% | $206.96M+17.4% | $205.15M+13.6% | $175.53M-0.7% | |
| Service revenue | $223.65M+12.1% | $215.49M+7.1% | $214.92M+5.8% | $209.58M+2.8% | $199.52M+2.7% | |
| Revenue, remaining performance obligation (as a percent) by Product | ||||||
| Customer commitment arrangements, multi-year arrangements | 26%+1.0pp | 28%0.0pp | 27%0.0pp | 26%0.0pp | 25%0.0pp | |
| Extended warranties and post contract support | 34%0.0pp | 40%0.0pp | 40%+1.0pp | 37%0.0pp | 34%+1.0pp | |
| Reagent rental arrangements | 26%+1.0pp | 24%-2.0pp | 30%+2.0pp | 26%+1.0pp | 25%+2.0pp | |
| Rebate and up-front considerations arrangements | 27%-1.0pp | 29%-5.0pp | 29%-3.0pp | 28%-2.0pp | 28%0.0pp | |
| Revenue by Product | ||||||
| CAG Diagnostics services and accessories | $36.61M+10.8% | $35.33M+9.7% | $34.1M+2.8% | $34.95M+7.7% | $33.05M+1.5% | |
| IDEXX VetLab consumables | $412.58M+19.7% | $389.05M+17.2% | $387.81M+17.8% | $375.11M+15.3% | $344.78M+8.8% | |
| Estimation of future revenues by Product | ||||||
| Customer commitment arrangements, multi-year arrangements | $4.9B+4.3% | $5B+13.6% | $4.7B+11.9% | $4.7B+14.6% | $4.7B+20.5% | |
| Extended warranties and post contract support | $9.4M+6.8% | $9.5M+9.2% | $9M-1.1% | $9.1M0.0% | $8.8M-7.4% | |
| Reagent rental arrangements | $102M+47.6% | $94.7M+37.0% | $75.6M+4.9% | $72.3M+13.0% | $69.1M+15.4% | |
| Total consolidated revenue by Geography | ||||||
| Latin America & Caribbean | $23.22M+16.2% | $25.06M+18.5% | $23.04M+9.8% | $22.33M+4.7% | $19.99M-1.3% | |
| Total Revenue by Geography | ||||||
| Asia Pacific | $94.38M+15.5% | $94.17M+13.0% | $90.72M+12.0% | $89.3M+11.0% | $81.73M+7.1% | |
| Canada | $40.94M+9.8% | $41.96M+9.7% | $41.38M+12.1% | $46.69M+13.9% | $37.3M+1.6% | |
| Europe, the Middle East and Africa | $257.05M+25.7% | $254.37M+22.5% | $245.06M+23.4% | $233.27M+16.2% | $204.55M+2.4% | |
| Latin America & Caribbean | $23.22M+16.2% | —— | $23.04M+9.8% | $22.33M+4.7% | $19.99M-1.3% | |
| United States | $725.23M+10.7% | $675.02M+11.8% | $705.04M+10.5% | $717.87M+8.7% | $654.86M+3.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Idexx Laboratories break its business down?
- Idexx Laboratories (IDXX) reports total revenue by business across 3 parts — CAG, LPD and Water segment revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Idexx Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Idexx Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
